Literature DB >> 11340541

Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy.

C J Grace1, J Lieberman, K Pierce, B Littenberg.   

Abstract

We conducted a retrospective study to determine the yield of blood samples drawn for culture during the initial 72 h of antibiotic therapy given to 139 patients who were admitted to the hospital for community-acquired infections or fever. The yield of these blood cultures was predictable and rarely (in only 1 patient [0.72%]) isolated new pathogens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11340541     DOI: 10.1086/320527

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  28 in total

1.  Usefulness of blood cultures in the management of febrile patients in long-term care facilities.

Authors:  R Raz; Y Ben-Israel; D Gronich; E Granot; R Colodner; I Visotzky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

2.  High levels of mecA DNA detected by a quantitative real-time PCR assay are associated with mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Ya-Chi Ho; Shan-Chwen Chang; Su-Ru Lin; Wei-Kung Wang
Journal:  J Clin Microbiol       Date:  2009-03-11       Impact factor: 5.948

3.  The potential for PCR based testing to improve diagnosis and treatment of sepsis.

Authors:  Ngan Lyle; John Boyd
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

4.  Use of PCR coupled with electrospray ionization mass spectrometry for rapid identification of bacterial and yeast bloodstream pathogens from blood culture bottles.

Authors:  Erin J Kaleta; Andrew E Clark; Desiree R Johnson; Dulini C Gamage; Vicki H Wysocki; Abdessalam Cherkaoui; Jacques Schrenzel; Donna M Wolk
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

Review 5.  Developments for improved diagnosis of bacterial bloodstream infections.

Authors:  A J M Loonen; P F G Wolffs; C A Bruggeman; A J C van den Brule
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-22       Impact factor: 3.267

6.  True bacteremias caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminants.

Authors:  M Rahkonen; S Luttinen; M Koskela; T Hautala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-31       Impact factor: 3.267

7.  A Diagnostic Stewardship Intervention To Improve Blood Culture Use among Adult Nonneutropenic Inpatients: the DISTRIBUTE Study.

Authors:  Valeria Fabre; Eili Klein; Alejandra B Salinas; George Jones; Karen C Carroll; Aaron M Milstone; Joe Amoah; Yea-Jen Hsu; Avinash Gadala; Sanjay Desai; Amit Goyal; David Furfaro; Jacquelyn Zimmerman; Susan Lin; Sara E Cosgrove
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

8.  Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia.

Authors:  Marie von Lilienfeld-Toal; Lutz E Lehmann; Ansgar D Raadts; Corinna Hahn-Ast; Katjana S Orlopp; Günter Marklein; Ingvill Purr; Gordon Cook; Andreas Hoeft; Axel Glasmacher; Frank Stüber
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

9.  Quantitative detection of Staphylococcus aureus and Enterococcus faecalis DNA in blood to diagnose bacteremia in patients in the intensive care unit.

Authors:  Remco P H Peters; Michiel A van Agtmael; Sonja Gierveld; Sven A Danner; A B Johan Groeneveld; Christina M J E Vandenbroucke-Grauls; Paul H M Savelkoul
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

10.  Streptococcus pneumoniae DNA load in blood as a marker of infection in patients with community-acquired pneumonia.

Authors:  Remco P H Peters; Richard F de Boer; Tim Schuurman; Sonja Gierveld; Mirjam Kooistra-Smid; Michiel A van Agtmael; Christina M J E Vandenbroucke-Grauls; Maike C J Persoons; Paul H M Savelkoul
Journal:  J Clin Microbiol       Date:  2009-08-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.